Why the study?
Does dynamic change of the systemic immune inflammation index predict early recurrence in patients with hepatocellular carcinoma after curative resection?
Does dynamic change of the systemic immune inflammation index predict early recurrence in patients with hepatocellular carcinoma after curative resection?
Serial monitoring of the systemic immune inflammation index may help predict early recurrence in patients with hepatocellular carcinoma after curative resection.
Answers are grounded in this paper and cite their sources.
May aid post-resection HCC recurrence risk stratification; leaves open prospective validation before clinical use.
The dynamic change and serial monitoring of the SII represent new indicators for predicting the early recurrence of HCC determining advance optimal therapy in advance.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: